Scribe Therapeutics, Inc 10-Q for FY2026 Q2
Scribe Therapeutics, Inc. (SCTX)
10-Q
2026-09-02
For: 2026-06-30
View Original
Added on
September 03, 2026
About this 10-Q
Scribe Therapeutics, Inc filed this 10-Q on September 2, 2026, covering the quarter ended June 30, 2026 (FY2026 Q2).
Headline figures
Quarter ended June 30, 2026, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $1.92M
- down 60.8% from $4.9M a year earlier
- Net loss
- $6.48M
- compared with a net loss of $9.9M a year earlier
- Diluted EPS
- -$2.62
- compared with -$4.08 a year earlier